| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $45.85B | $38.70B | $35.35B |
| YoY Revenue Growth % | +18.5% | +9.5% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $10.27B | $7.74B | $11.19B |
| Operating Margin % | 22.4% | 20.0% | 31.7% |
| Net Income (GAAP) | $8.70B | $6.56B | $9.48B |
| EBITDA (Normalized) | $11.92B | $9.13B | $12.46B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $8.54B | $4.71B | $5.19B |
| Capital Expenditures (CapEx) | $2.06B | $1.74B | $1.59B |
| Free Cash Flow (FCF) | $6.47B | $2.97B | $3.60B |
| FCF Margin % | 14.1% | 7.7% | 10.2% |
| Return on Invested Capital (ROIC %) | 14.9% | 11.7% | 8.2% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $50.07B | $46.61B | $41.63B |
| Total Stockholders' Equity | $18.68B | $19.34B | $85.40B |